Skip to main content

Prins Richard K's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Aug 13, 2024

Accession no.
0001415889-24-021242
Filed
Aug 13, 2024
Trade date
Aug 12, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $736.5K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Prins Richard KCIK 0001047579Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 12, 2024Common StockMOption exerciseAcquired+3,915$20.03+$78,417.4537,886Direct
Aug 12, 2024Common StockMOption exerciseAcquired+6,004$20.08+$120,560.3243,890Direct
Aug 12, 2024Common StockMOption exerciseAcquired+7,182$19.52+$140,192.6451,072Direct
Aug 12, 2024Common StockSSaleDisposed−17,101$43.07−$736,540.0733,971Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 12, 2024Common StockMOption exerciseDisposed−3,915$0.00$010,000Direct
Aug 12, 2024Common StockMOption exerciseDisposed−6,004$0.00$010,000Direct
Aug 12, 2024Common StockMOption exerciseDisposed−7,182$0.00$010,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)